PuraPharm announces disposal of accounts receivables for HKD15m
PuraPharm Corporation Limited (HKEX:1498) announced a discloseable transaction involving the disposal of accounts receivables. The company's indirect wholly-owned subsidiary, Nong's Company Limited, entered into a disposal agreement with Intrabase Financial Services Limited on June 10, 2025, to dispose of the receivables for a consideration of HKD15,000,000. The book value of the accounts receivables is approximately HKD15,594,000. The disposal is classified as a discloseable transaction under the Listing Rules because the relevant percentage ratios are more than 5% but less than 25%. PuraPharm intends to use the proceeds from the disposal for general working capital. The company anticipates recording costs of approximately HKD150,000 related to the transaction.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when PURAPHARM publishes news
Free account required • Unsubscribe anytime